Evidence map›Paper›PMID 40900671›Full record

ArticleInflammatory bowel diseases2025

Functional Profiling Demonstrates That a Sulfide-Reducing Diet Achieves Microenvironmental Targets in Ulcerative Colitis.

Alice S Day, Rachael Slater, Remy B Young, Reuben Z Wheeler, Vanessa R Marcelino, Natasha K Maddigan, Samuel C Forster, Samuel P Costello, Wendy Uylaki, Chris S J Probert and 4 more

Abstract read
In one paragraph

Article in Inflammatory bowel diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Metabolic engineering ofbioRxiv : the preprint server for biology · 2026
    Article
  3. The Challenges of Performing Controlled Trials of Diet Therapies in Gastroenterology.JGH open : an open access journal of gastroenterology and hepatology · 2026
    Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Alice S DayInflammatory Bowel Disease Service, Department of Gastroenterology and Hepatology, Queen Elizabeth Hospital, Adelaide, SA, Australia.ORCID 0000-0003-4905-5056
Rachael SlaterDepartment of Molecular and Clinical Cancer, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.ORCID 0000-0001-9765-6978
Remy B YoungCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.ORCID 0000-0002-1458-2895
Reuben Z WheelerCollege of Science and Engineering, Flinders University, Bedford Park, SA 5042, Australia.ORCID 0009-0003-0458-0938
Vanessa R MarcelinoMelbourne Integrative Genomics, Department of Microbiology and Immunology, Peter Doherty Institute, School of BioSciences, University of Melbourne, Melbourne, VIC 3010, Australia.ORCID 0000-0003-1755-0597
Natasha K MaddiganBasil Hetzel Research Institute, School of Medicine, Faculty of Health Sciences, University of Adelaide and University of South Australia, Adelaide, SA, Australia.ORCID 0000-0002-3238-1157
Samuel C ForsterCentre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.ORCID 0000-0003-4144-2537
Samuel P CostelloInflammatory Bowel Disease Service, Department of Gastroenterology and Hepatology, Queen Elizabeth Hospital, Adelaide, SA, Australia.ORCID 0000-0002-2857-1812
Wendy UylakiInflammatory Bowel Disease Service, Department of Gastroenterology and Hepatology, Queen Elizabeth Hospital, Adelaide, SA, Australia.ORCID 0009-0003-2937-863X
Chris S J ProbertDepartment of Molecular and Clinical Cancer, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.ORCID 0000-0003-4550-0239
Jane M AndrewsSchool of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, SA, Australia.ORCID 0000-0001-7960-2650
Chu K YaoDepartment of Gastroenterology, School of Translational Research, Monash University and Alfred Health, Melbourne, VIC, Australia.ORCID 0000-0003-4286-4942
Peter R GibsonDepartment of Gastroenterology, School of Translational Research, Monash University and Alfred Health, Melbourne, VIC, Australia.ORCID 0000-0001-9108-1712
Robert V BryantInflammatory Bowel Disease Service, Department of Gastroenterology and Hepatology, Queen Elizabeth Hospital, Adelaide, SA, Australia.ORCID 0000-0003-4229-3289

Funding

Commonwealth Research StipendEuropean Crohn's ColitisGastrointestinal Society of Australia FICEHospital Research FoundationUniversity of Adelaide
6 · The paper itself

Abstract

backgroundAs a dietary approach to reducing inflammation in ulcerative colitis, the 4-SURE (4 Strategies to Sulfide Reduction) diet was designed to correct pathogenic alterations of excessive protein fermentation and hydrogen sulfide (H2S) production in the distal colon. We aimed to perform a deep functional analysis (microbial and metabolomic) of the feces of 28 adults with mild-moderately active ulcerative colitis who adhered to the 4-SURE diet over 8 weeks to explore whether the 4-SURE diet could modulate the intraluminal environment as intended.

methodsFecal samples were collected at week 0 and 8 of dietary intervention, processed and aliquoted. Metagenomic sequencing was undertaken to identify changes in H2S-metabolizing genes, while gas chromatography-mass spectrometry was used to analyze fecal volatile organic compounds and H2S production.

resultsThe 4-SURE diet significantly increased alpha diversity between weeks 0 and 8. By random forest plot classifier, the abundance of taxonomic groups comprising known H2S-producing genera were markedly lower at week 8, specifically Odoribacter and Peptostreptococcaceae, and were of highest importance in discriminating between before- and after-diet samples. The capacity for bacterial H2S metabolism was altered with diet, with differences in 12 of 67 analyzed sulfur-metabolizing genes identified. H2S production and indole, a specific marker of protein fermentation, were significantly decreased due to the diet.

conclusionsHere, we demonstrate that the objectives of the 4-SURE diet were fulfilled. This application of deep functional analysis to a dietary intervention study is novel and highlights an exemplar framework for including microbial and metabolomic biomarkers of pathogenic relevance in the analysis of therapeutic diet strategies. (Australian New Zealand Clinical Trials Registry, Number: ACTRN12619000063112).

Indexed as

Colitis, UlcerativeDietGastrointestinal MicrobiomeHydrogen SulfideSulfidesAdultFecesFemaleHumansMaleMiddle AgedVolatile Organic CompoundsHydrogen SulfideSulfidesVolatile Organic Compounds

Identifiers

PMID40900671
PMCPMC12638066

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.